Anthony J. Recupero - Oct 2, 2024 Form 4 Insider Report for SI-BONE, Inc. (SIBN)

Role
President, Commercial Ops
Signature
/s/ Michael A. Pisetsky, Attorney-in-Fact for Anthony J. Recupero
Stock symbol
SIBN
Transactions as of
Oct 2, 2024
Transactions value $
-$57,403
Form type
4
Date filed
10/4/2024, 06:55 PM
Previous filing
Aug 20, 2024
Next filing
Nov 20, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SIBN Common Stock Sale -$21.1K -1.55K -0.66% $13.58 235K Oct 2, 2024 Direct F1, F2
transaction SIBN Common Stock Sale -$23.8K -1.75K -0.74% $13.58 233K Oct 2, 2024 Direct F1, F2
transaction SIBN Common Stock Sale -$12.5K -921 -0.39% $13.60 232K Oct 3, 2024 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
F2 This transaction was executed in multiple trades at prices ranging from $13.34 USD to $13.71 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan.
F4 Includes 137,761 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock.